The receptor tyrosine kinase ErbB-2 (Her-2/Neu) is overexpressed in 25 – 30% of all human breast cancers, and is associated with a poor prognosis and an increased likelihood of metastasis (Slamon et al, 1987). Here, ERBB2 is linked to breast carcinoma.